These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8995511)

  • 1. The effect of vincristine-polyanion complexes in STEALTH liposomes on pharmacokinetics, toxicity and anti tumor activity.
    Zhu G; Oto E; Vaage J; Quinn Y; Newman M; Engbers C; Uster P
    Cancer Chemother Pharmacol; 1996; 39(1-2):138-42. PubMed ID: 8995511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?
    Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Xiu X; Li Y; Wei N
    J Pharm Sci; 2011 Jul; 100(7):2835-48. PubMed ID: 21305545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.
    Krishna R; Webb MS; St Onge G; Mayer LD
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1206-12. PubMed ID: 11504822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine.
    Webb MS; Saxon D; Wong FM; Lim HJ; Wang Z; Bally MB; Choi LS; Cullis PR; Mayer LD
    Biochim Biophys Acta; 1998 Jul; 1372(2):272-82. PubMed ID: 9675310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylation alleviates the non-specific toxicities of Alpha-Momorcharin and preserves its antitumor efficacy in vivo.
    Deng NH; Wang L; He QC; Zheng JC; Meng Y; Meng YF; Zhang CJ; Shen FB
    Drug Deliv; 2016; 23(1):95-100. PubMed ID: 24786488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate.
    Zhang J; Chen Y; Li X; Liang X; Luo X
    Int J Nanomedicine; 2016; 11():4187-97. PubMed ID: 27616886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a stable single-vial liposomal formulation for vincristine.
    Mao W; Wu F; Lee RJ; Lu W; Wang J
    Int J Nanomedicine; 2019; 14():4461-4474. PubMed ID: 31296986
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics and anti-tumor activity of vincristine encapsulated in sterically stabilized liposomes.
    Allen TM; Newman MS; Woodle MC; Mayhew E; Uster PS
    Int J Cancer; 1995 Jul; 62(2):199-204. PubMed ID: 7622296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates.
    Shah NN; Cole DE; Lester-McCully CM; Wayne AS; Warren KE; Widemann BC
    Invest New Drugs; 2016 Feb; 34(1):61-5. PubMed ID: 26661090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients.
    Bedikian AY; Vardeleon A; Smith T; Campbell S; Namdari R
    J Clin Pharmacol; 2006 Jul; 46(7):727-37. PubMed ID: 16809798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
    Allen TM; Mehra T; Hansen C; Chin YC
    Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
    Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
    J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques.
    Mayer LD; St-Onge G
    Anal Biochem; 1995 Dec; 232(2):149-57. PubMed ID: 8747469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome encapsulated vincristine: preclinical toxicologic and pharmacologic comparison with free vincristine and empty liposomes in mice, rats and dogs.
    Kanter PM; Klaich GM; Bullard GA; King JM; Bally MB; Mayer LD
    Anticancer Drugs; 1994 Oct; 5(5):579-90. PubMed ID: 7858291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection.
    Embree L; Gelmon K; Tolcher A; Hudon N; Heggie J; Dedhar C; Logan P; Bally MB; Mayer LD
    Cancer Chemother Pharmacol; 1998; 41(5):347-52. PubMed ID: 9523729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes.
    Vaage J; Donovan D; Mayhew E; Uster P; Woodle M
    Int J Cancer; 1993 Jul; 54(6):959-64. PubMed ID: 8335404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine.
    Silverman JA; Deitcher SR
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):555-64. PubMed ID: 23212117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are PEGylated liposomes better than conventional liposomes? A special case for vincristine.
    Wang X; Song Y; Su Y; Tian Q; Li B; Quan J; Deng Y
    Drug Deliv; 2016 May; 23(4):1092-100. PubMed ID: 26024386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged circulation and increased tumor accumulation of liposomal vincristine in a mouse model of rhabdomyosarcoma.
    Roveri M; Pfohl A; Jaaks P; Alijaj N; Leroux JC; Luciani P; Bernasconi M
    Nanomedicine (Lond); 2017 May; 12(10):1135-1151. PubMed ID: 28447920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.